Sign up to save your podcasts
Or
Share The EPIC-CAD Trial
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The EPIC-CAD Trial
Gi-Byoung Nam, Duk-Woo Park, and C. Michael Gibson weigh edoxaban monotherapy vs dual antithrombotic therapy for patients with AF and stable coronary artery disease.
View all episodes
By TCTMD
4
22 ratings
Gi-Byoung Nam, Duk-Woo Park, and C. Michael Gibson weigh edoxaban monotherapy vs dual antithrombotic therapy for patients with AF and stable coronary artery disease.
More shows like Talking Points
View all
JAMA Editors' Summary
136 Listeners
NEJM This Week
323 Listeners
JACC This Week
172 Listeners
This Week in Cardiology
884 Listeners
JAMA Clinical Reviews
501 Listeners
AFP: American Family Physician Podcast
703 Listeners
Heart Sounds Podcast
12 Listeners
White Coat Investor Podcast
2,424 Listeners
The Curbsiders Internal Medicine Podcast
3,334 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
137 Listeners
Core IM | Internal Medicine Podcast
1,144 Listeners
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
58 Listeners
Annals On Call Podcast
190 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
366 Listeners
Cardionerds: A Cardiology Podcast
429 Listeners